Goldstein Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Goldstein Advisors's JNJ Position: Q2 2026 in Review
Goldstein Advisors increased its Johnson & Johnson (JNJ) stake by 9.8% in Q2 2026, buying an estimated $81.8K and bringing the position to 3,947 shares worth $1M. The position accounts for 0.09% of the portfolio, ranked #82.
Goldstein Advisors first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Goldstein Advisors held 3,947 shares of Johnson & Johnson worth $1M as of Q2 2026.
- Goldstein Advisors bought 351 Johnson & Johnson shares in Q2 2026, an estimated $81.8K.
- Johnson & Johnson made up 0.09% of Goldstein Advisors's portfolio in Q2 2026, its #82 holding.
- Goldstein Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
- 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Goldstein Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.